This is demonstrated by Her-2 enriched Her-2-IHC negative tumors in human breast cancer [41] and ER-target gene enrichment in ER-IHC-negative microacinar tumors from mouse mammary tumor models. The gene discussed is ESR1; the disease is breast carcinoma.